U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


Senators Warn Trump Against Unauthorized Venezuela Strike, Vow War Powers Push
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Trump’s Name Appears on U.S. Institute of Peace Ahead of Rwanda–Congo Deal Signing
UN General Assembly Demands Russia Return Ukrainian Children Amid Ongoing Conflict
Trump Pardons Former Honduran President Juan Orlando Hernández in Controversial Move
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Peru Moves to Declare State of Emergency at Chile Border as Migrant Tensions Rise
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Germany Moves to Approve €2.9 Billion Defense Procurement Package
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 



